Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07314853) titled 'Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: National Cancer Institute, Naples
Condition:
Neoplasm
Cancer
Hemodynamic (MAP) Stability
Cancer Surgery
Artificial Intelligence (AI)
Fluid Therapy DURING SURGERY
Intervention:
Other: Artificial Intelligence-Assisted Fluid Management
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment...